Point: Counterpoint: Hypoxia is/ is not the optimal means of reducing pulmonary blood flow in the pre-operative single ventricle heart. Point: Hypoxia is the optimal means of reducing pulmonary blood flow in the pre-operative single ventricle heart
It was over 60 years ago that the idea of hypoxia induced pulmonary vasoconstriction was first proposed and this idea has been put to the test and validated many times in the past half century. In the normal heart, hypoxia to segments of lung, typically due to atelectasis or infiltrate, induces local pulmonary vasoconstriction which minimizes ventilation-perfusion mismatching. For a patient with normal heart and lungs, this is a very effective way of limiting intrapulmonary right to left shunting of deoxygenated blood, thereby maintaining stable arterial oxygen saturations.
It is generally accepted that balancing the pulmonary (Qp) and systemic blood flows (Qs) is the best way of stabilizing the circulation in patients with single ventricle. These patients, however, often respond very differently to common interventions such as the administration of oxygen and mechanical ventilation. How will the pulmonary vasculature bed of a single ventricle patient respond to not just isolated lung segment hypoxia, but to global hypoxia?
Barnea developed a wonderful mathematical model of the univentricular circulation 1 and tested it through various manipulations of cardiac output, systemic arterial and venous oxygen saturations, pulmonary venous oxygen saturations, and Qp:Qs. He demonstrated that maximal oxygen delivery to the tissues would be obtained by Qp:Qs slightly less than 1 and that for higher Qp:Qs ratios, oxygen delivery to the tissues would actually decrease. He also showed that with systemic arterial oxygen saturations greater than a certain value that was determined by cardiac output (typically in the 70-85% range), oxygen delivery falls off precipitously.
Various approaches aimed at normalizing Qp:Qs by either decreasing Qp or increasing Qs have been advocated by different authors [2] [3] [4] [5] [6] . Controversy exists, however, as different centers with different approaches typically have equally good results with this patient population. Determining the optimal means of reducing Qp and thereby stabilizing circulation in the univentricular heart continues to be debated, although methods that mimic the stable fetal circulation seem to be most effective. In the womb, the fetus is hypoxic with oxygen saturations between 30-60% 7 ; pulmonary vascular resistance is high, and systemic vascular resistance is low, with systemic blood flow being supplied by the ductus arteriosus. Hypoxia allows one to duplicate this stable physiology in the newborn infant ( Figure 1B) . Using his mathematical model, Barnea calculated that ideal Qp:Qs balance would be obtained in patients with hypoplastic left heart syndrome by keeping arterial blood gases near the following parameters: pH ~ 7.4, arterial partial pressure of carbon dioxide (PaCO 2 )~40 millimeters of mercury, with arterial partial pressure of oxygen (PaO 2 )~40 millimeters of mercury, and arterial saturation ~75%. This, he suggests, could easily be managed by maintaining the patient in either room air, or by creating an hypoxic environment by adding additional nitrogen to lower the inspired concentration of oxygen.
Reddy developed a fetal animal model of single ventricle physiology in lambs and tested various therapies aimed at altering pulmonary vascular resistance and flow and measured several hemodynamic parameters 8 . As one would expect, 100% oxygen proved to be a potent pulmonary vasodilator and resulted in a significant decrease in pulmonary vascular resistance with subsequent dramatic increase in Qp:Qs. Hypoxia produced a significant increase in pulmonary artery pressure of >20% that of baseline. Additionally, there was a significant decrease in systemic arterial pressure of >10% with subsequent decrease in Qp:Qs by over 32% to an average value of ~1.19 ( Figure 1B) . As shown by Barnea, Qp:Qs values near 1 are important for optimal tissue oxygen delivery in the univentricular patient.
An excellent study by Tabbutt looked at hypoxia and hypercarbia in patients with hypoplastic left heart syndrome before surgical palliation 9 . They found that both hypoxia and hypercarbia decreased the Qp:Qs. Hypercarbia, however, was associated with a significant increase in the PaCO 2 and decrease in pH. Hypoxia, on the other hand, is well tolerated in the newborn. The persistence of fetal hemoglobin in these infants allows for better tissue oxygen delivery at lower PaO 2 , similar to that of the fetus, when oxygen saturations between 30-60% are typical 7 . Day 3 reported a series of patients with hypoplastic left heart syndrome and similar lesions treated effectively with hypoxia. They were able to increase the inspired nitrogen to maintain systemic oxygen saturations near 75% 3 . For those being supported through mechanical ventilation, this was accomplished via the respiratory circuit. For those breathing spontaneously, additional nitrogen was supplied via nasal cannula. 80% survived to either transplant or 1 st stage palliation while the 20% that died did so at 1-3 months of age while awaiting transplant. Autopsy of these patients did not yield any hypoxia induced pulmonary vascular changes. This study also commented that there were no instances of necrotizing enterocolitis (NEC) despite enteral feeding. NEC is a serious complication in premature infants and infants with ductal dependent systemic circulation. It is felt that decreased oxygen delivery to the intestinal wall, and diminished perfusion pressure related to the diastolic flow run off across the ductus arteriosus, combined with the increased metabolic demands associated with enteral feedings, play a role in the development of NEC 10 . For this reason, many institutions delay enteral feedings in patients with ductal dependant univentricular circulation until after surgical palliation. The authors of this paper suggest that this decreased incidence of NEC was due to improved bowel perfusion and tissue oxygen delivery related to increasing pulmonary vascular resistance, thereby decreasing diastolic flow reversal in the systemic circulation. This allowed for earlier enteral feedings and improved nutrition prior to surgical intervention.
In conclusion, hypoxia is the optimal means of reducing pulmonary blood flow in preoperative patients with single ventricle hearts. This can easily be facilitated by increasing nitrogen in the inspired gases without the need for mechanical ventilation in most patients. This allows for more normal newborn behaviors such as enteral feeding and being held by the parents prior to surgical palliation. The hypoxia itself is well tolerated in newborns with persistence of fetal hemoglobin, more readily mimicking the fetal state in which they were so stable. Single ventricle physiology, as exemplified by hypoplastic left heart syndrome (HLHS), is characterized by complete intra-cardiac mixing of pulmonary and systemic venous return and a functional single great artery. As pulmonary vascular resistance (PVR) falls in the early postnatal period, blood flow is diverted to the lungs (Qp), often at the expense of the systemic (Qs) and coronary circulations (14) . This Qp:Qs mismatch imposes three physiologic perturbations: 1) excessive Qp leads to pulmonary edema and tachypnea and hence augments the global metabolic rate, 2) excessive Qp results in an added volume load to the single ventricle, with that chamber often seeing 3-4 times its intended volume, resulting in ventricular dysfunction and valvar regurgitation, and 3) Qs may fall, leading to diminished oxygen delivery (DO 2 ), acidosis, necrotizing enterocolitis, renal and hepatic dysfunction, and other complications (14, 18) . We contend that therapeutic hypoxia by administration of inhaled nitrogen (N 2 ) can address some of these concerns, but is inadequate in severe cases where augmented oxygen delivery is needed most. Additionally, we assert there are therapies that are ultimately superior to hypoxia for some clinical scenarios.
In single ventricle pre-operative physiology, flow to the systemic vs. pulmonary vascular beds is determined primarily by their relative resistances. Generally, systemic vascular resistance (SVR) is less amenable to independent pharmacologic manipulation than is PVR, and so PVR has become the target for balancing blood distribution in these cases. PVR has multiple determinants, both mechanical and humoral (1, 8, 11, 16) . The alveolar partial pressure of oxygen (PAO 2 ) and carbon dioxide (PCO 2 ) are critically important mediators of ventilation-perfusion matching (23). Both hypoxia (30) and hypercarbia (10) diminish pulmonary blood flow, but in large part due to its ease of administration, therapeutic hypoxia by the addition of inhaled N2 has gained greater use.
In some centers, neonates with HLHS awaiting heart transplantation have been kept on inhaled N 2 for prolonged periods of time, up to a month or more, with good reported results (6, 7).
Why then should a practitioner consider alternative therapies to control pulmonary blood flow when hypoxia has been shown to be beneficial? To address that question one must explore the potential detriments of hypoxic therapy and review the literature comparing it to alternate therapies.
The Fick equation can be manipulated in the single ventricle heart (15) There is an additional concern regarding hypoxic gas therapy. As the PaO 2 falls, the patient's gas mechanics operate on the nearly vertical portion of the oxygen- vs. CO 2 and found that both strategies clearly induced the desired fall of Qp:Qs, however, hypoxic gas did not improve DO 2 , while CO 2 therapy increased DO 2 by 44%.
Furthermore, there is evidence that hypercapnic acidosis is a lung protective strategy that preserves pulmonary mechanics, attenuates lung protein leakage, reduces pulmonary edema, and improves DO 2 in an animal model of lung injury (12, 13) . Interestingly, hypercapnic acidosis affords greater protection than metabolic acidosis, and buffering hypercapnic acidosis with NaHCO 3 attenuates its protective effects in acute lung injury, suggesting that elevated CO 2 per se rather than low pH confers protection (12) . The protective effect of hypercapnic acidosis is not confined to the lung. Mild hypercapnia protects the perinatal brain from hypoxic-ischemic damage (29), prevents myocardial stunning in ischemia reperfusion (26), and shifts the oxygen-hemoglobin dissociation curve to the right, improving tolerance to hypoxia at the tissue level.
It is important to note the inherent limitations of CO 2 therapy. Infants will invariably hyperventilate to normalize pH and pCO 2 when given exogenous CO 2 . To achieve the desired hypercapnic acidosis, mechanical ventilation and muscle paralysis may be necessary. Additionally, over time, a compensatory metabolic alkalosis will develop. Nonetheless, the study by Tabutt et al. (28) provides a compelling rationale for the use of short term inhaled CO 2 over hypoxic therapy for patients in shock with inadequate DO 2 requiring mechanical ventilation; that is, those patients needing therapy most.
We are not advocating that inhaled CO 2 be used in every case of HLHS prior to operative repair. In fact, it rarely is necessary. In most, the diagnosis is made prior to a shock presentation, and a high a Qp:Qs can be tolerated for short periods of time until the Norwood operation is performed, a procedure which ultimately resolves this dilemma through the use of a restrictive shunt to the pulmonary vasculature (4) . The practitioner also must be aware that a high Qp:Qs may represent a Qs that is too low rather than a Qp that is too high, and so must ensure that the ductus arteriosus is widely patent, that there is not significant valvar regurgitation, and that ventricular function is adequate. Some have proposed vasodilator therapy with the aim of diminishing SVR in an attempt to augment Qs and subsequently improve DO 2 (27). Finally, we must admit to you, the reader (and unfortunately also to our antagonist, Dr. Ebenroth), that we do in fact utilize hypoxic gas therapy in situations where the patient is excessively tachypneic and at risk of hemodynamic decompensation awaiting surgical repair. Nonetheless, we can emphatically state that surgery, not hypoxia, is the optimal means of reducing pulmonary blood flow in the single ventricle heart. In those situations where the patient is critically ill with shock, inhaled CO 2 has been shown in the best prospective comparison study to outperform hypoxia because it not only reduces pulmonary flow but also improves oxygen delivery. By their own admission, they utilize an hypoxic environment in their institution to manage recalcitrant patients at risk of hemodynamic decompensation. Hypercarbia requires mechanical ventilation to handle the associated elevated PCO 2 and can create an acidotic milieu which patients with hypoplastic left heart syndrome will not tolerate.
Nitrogen is superior to hypercarbia in that it does not alter pH and does not require mechanical ventilation 3 . The added benefits of remaining extubated and bonding with one's parents should not be underestimated. Research has shown that infants who are given adequate maternal contact early after birth have better psycho-motor development, especially in gross motor and language skills, than infants that experience a paucity of maternal contact 4 . I contend that hypoxia, accomplished by the addition of nitrogen, either through the ventilatory circuit of intubated patients, or via nasal cannula in spontaneously breathing patients, is the best way to reduce pulmonary blood flow in the pre-operative single ventricle heart.
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which would be considered extreme in the treatment of humans. Importantly, 5% CO 2 improved Qp:Qs and increased DO2, similar to Tabutt's findings in humans (7).
Some of Dr. Ebenroth's references pertain to the post-operative single ventricle heart, in which Qp is limited by a restrictive shunt (3, 8) . We do not feel those studies apply to this discussion.
Our opponent suggests that hypoxia allows recapitulation of stable fetal physiology in the newborn. Unfortunately, we have not yet been able to replicate the in utero environment postnatally, and it is unlikely that the transitioning newborn undergoing fluctuations in PVR can achieve stability comparable to the fetus in whom gas exchange is performed by the placenta.
"Hypoxia … is well tolerated in the newborn." We counter that the long-term effects of postnatal hypoxia are poorly understood. In fact, recent data suggest that postnatal hypoxia, as seen in the pre-operative patient with transposition of the great arteries, is associated with brain injury (periventricular leukomalacia) (5). Conversely, hypercapnic acidosis has been shown to have cerebral and pulmonary protective effects in term and preterm infants at risk for hypoxic ischemic encephalopathy and chronic lung disease (2, 4, 9) .
We concede the point that hypoxic gas therapy is simpler to administer than hypercarbia, and cautiously advocate its role in the minimally symptomatic neonate in whom surgery is not readily available, with concomitant cerebral near infrared spectroscopy monitoring to assure appropriate DO 2 . We maintain, however, for infants who present critically ill in shock, hypercarbia is the preferred therapy because it not only limits pulmonary flow, but also augments DO 2 .
There is only one real sin and that is to persuade oneself that the second best is anything but second best.
-Doris Lessing
